Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in pediatric patients
2010-022872-30Phase 3Completed
- Sponsor
- Helsinn
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of palonosetron and ondansetron in chemotherapy-induced nausea and vomiting (CINV) (3 arms), sponsored by Helsinn. Primary endpoint: Complete response in acute phase. Started Dec 2010; status: completed.
02
Drugs
palonosetronondansetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on 2010-022872-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022872-30.